News & Events
Dr. Barrett Introduces Patients to Leading Cornea Treatment Technology
Dr. Ryan Barrett is the only eye surgeons in the area to specialize in FDA-approved corneal collagen cross-linking. This procedure is the first therapeutic treatment that has been rigorously tested and FDA-approved for keratoconus and other forms of corneal ectasia. Designed to strengthen and stabilize the weakened links bonding the corneal fibers together, corneal cross-linking preserves vision quality and is 92-97% effective at preventing future progression of keratoconus.
Maria R., another happy patient with the results of crosslinking.
Now Offering iStent for Patients with Cataracts & Glaucoma
For patients dealing with both cataracts and glaucoma, Hollingshead Eye Center offers state-of-the-art MIGS technology. MIGS includes microsurgical implants that can be placed in the eye at the time of cataract surgery to decrease eye pressure and thus decrease the need for glaucoma drops or the risk of vision loss from glaucoma. MIGS devices include the iStent inject, the world’s smallest medical implant, and the Hydrus. These are designed to lower eye pressure by improving the eye’s natural fluid outflow and may be inserted during cataract surgery. Covered by Medicare and most private insurance plans, MIGS is a convenient way to receive treatment for both eye conditions simultaneously. It may also reduce reliance on glaucoma medication.
During August Hollingshead Eye Center Observes Cataract Awareness Month
Dr. Mark Hollingshead of Hollingshead Eye Center expects to be handling more questions about what a cataract is - and explaining what it is not during Cataract Awareness Month. Read the full press release.